Our professionals
Dr. Teresa Iscar
Pathology Specialist.
Primary focus on the study of breast pathology, gynecologic pathology, head and neck pathology, and thyroid pathology.
Works at:
Madrid headquarters
Be part of:
Clínica Universidad de Navarra
Cancer Center Clínica Universidad de Navarra
INDEX H
2
Professional career
Medical Degree (MD) in 1997 and PhD in Medicine (2017) from CEU San Pablo University.
Specialist in Pathology, Autonomous University of Madrid.
Clinical Research Fellow (2004) at Ipatimup (University of Porto).
Department of Pathology, Hospital Pedro Hispano ULS-Matosinhos-EPE (Matosinhos–Porto, Portugal) (2004–2009).
Hospital Universitario del Henares (Coslada, Madrid) (2009–2011).
Hospital Universitario Príncipe de Asturias (Alcalá de Henares) (2011–2012).
Hospital Universitario Rey Juan Carlos (Móstoles) (2012–2014).
Coordinator – Head of the Pathology Department, HM Puerta del Sur Hospital, Móstoles (HM Group) (2014–2019).
RESEARCH AREAS
- Collaborating member of the PD-L1 expression study in triple-negative breast carcinomas (HM Hospitals Research Foundation and ROCHE Farma S.A.), 2018/19.
- Study of changes in the immune microenvironment of advanced ovarian cancer in patients receiving neoadjuvant chemotherapy with or without bevacizumab in the GEICO 1205 clinical trial (GEICO 37-O), resulting in the following publication: "Analysis of tumor microenvironment changes after neoadjuvant chemotherapy with or without bevacizumab in advanced ovarian cancer (GEICO-89T/MINOVA study)".
AREAS OF INTEREST
- Study of the diagnosis and treatment of patients with breast cancer, especially the triple-negative molecular subtype.
- Research on the tumor microenvironment in gynecologic cancer.
Activity
In teaching
- Honorary Lecturer, Autonomous University of Madrid, Department of Pathology (Academic Years 2000/2001 and 2002/2003).
- Instructor in the Advanced Vocational Training Program for Pathology and Cytodiagnosis Technicians, HM Institute of Health Professions (2015).
- Assistant Instructor for practical pathology classes (2016–2019).
- Tenured Associate Professor (PhD), Department of Medical Sciences, Faculty of Medicine, CEU San Pablo (2017–2019).
- Courses taught (2017–2018): “Practical Application Course on ASCO-CAP Guidelines for HER2 Testing in Breast Cancer”, held at HM Sanchinarro University Hospital.
In research
- Delivered three courses in 2018–2019 on assessing PD-L1 expression in triple-negative breast cancer following FDA approval of atezolizumab as first-line therapy in women with locally advanced or metastatic disease.
- Associate Clinical Researcher, CCUN Research Group in gynecologic cancer.